AudioCure Pharma GmbH: AudioCure Pharma Receives Hearing Technology Innovator Award for its Innovative Compound AC102 for the Treatment of Sudden Hearing Loss
Kort samengevat
AudioCure Receives Hearing Technology Innovator Award for AC102 in Therapeutics Category A Phase 2 clinical trial evaluating the efficacy, safety and tolerability of AC102 in patients with
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij FinanzNachrichten.de.
Lees het volledige bericht ↗